LEXARIA BIOSCIENCE CORP. Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net
LEXARIA BIOSCIENCE CORP. (LEXX) had Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net of $0 as of 2021-11-30, per its 10-Q filed 2022-01-14.
Discontinued › Balance Sheet › Assets › Assets, Current › Disposal Group, Including Discontinued Operation, Assets, Current
us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet · last filed 2022-01-14
- 2021-11-30: Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net $0.00.
- 2021-08-31: Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net $0.00.
- 2021-05-31: Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net $0.00.
- 2021-02-28: Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net $0.00.
| Period end | Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net |
|---|---|
| 2021-11-30 | $0.00 10-Q · filed 2022-01-14 |
| 2021-08-31 | $0.00 10-K · filed 2021-11-29 |
| 2021-05-31 | $0.00 10-Q · filed 2021-07-15 |
| 2021-02-28 | $0.00 10-Q · filed 2021-04-14 |
| 2020-11-30 | $49.33K 10-Q · filed 2021-01-14 |
| 2020-08-31 | $105.25K 10-K · filed 2021-11-29 |
| 2020-08-30 | $49.33K 10-Q · filed 2022-01-14 |
| 2020-05-31 | $105.25K 10-Q · filed 2021-07-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |